Literature DB >> 7053190

Symptomatic relapse after oral vancomycin therapy of antibiotic-associated pseudomembranous colitis.

J G Bartlett, F J Tedesco, S Shull, B Lowe, T Chang.   

Abstract

Twenty patients with antimicrobiol-associated diarrhea had a symptomatic relapse after oral vancomycin therapy. All patients had stool examinations which implicated C. difficile as the causative agent, and 16 had pseudomembranous colitis. Clinical courses were characterized by resolution of symptoms with recurrence of diarrhea at 4--21 days after vancomycin was discontinued. Studies of stools collected sequentially showed that vancomycin failed to eliminate C. difficile despite susceptibility to this agent with in vitro testing. A review of our records shows the incidence os symptomatic relapse is approximately 14%. This experience emphasizes the importance of adequate follow-up in patients treated with oral vancomycin for antibiotic-associated diarrhea or colitis due to C. difficile.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7053190

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  39 in total

Review 1.  Clostridium difficile toxins: mechanism of action and role in disease.

Authors:  Daniel E Voth; Jimmy D Ballard
Journal:  Clin Microbiol Rev       Date:  2005-04       Impact factor: 26.132

2.  Effect of yogurt on clindamycin-induced Clostridium difficile colitis in hamsters.

Authors:  C M Kotz; L R Peterson; J A Moody; D A Savaiano; M D Levitt
Journal:  Dig Dis Sci       Date:  1992-01       Impact factor: 3.199

3.  The role of anion-exchange resins in the treatment of antibiotic-associated pseudomembranous colitis.

Authors:  R E Ariano; G G Zhanel; G K Harding
Journal:  CMAJ       Date:  1990-05-15       Impact factor: 8.262

4.  Bacitracin therapy in antibiotic-associated pseudomembranous colitis.

Authors:  F J Tedesco
Journal:  Dig Dis Sci       Date:  1980-10       Impact factor: 3.199

5.  Clostridium difficile associated diarrhoea in hospitalised patients: onset in the community and hospital and role of flexible sigmoidoscopy.

Authors:  S S Johal; J Hammond; K Solomon; P D James; Y R Mahida
Journal:  Gut       Date:  2004-05       Impact factor: 23.059

6.  Clostridium difficile-associated diarrhoea in uremic patients.

Authors:  B Aronsson; P Barany; C E Nord; B Nyström; P Stenvinkel
Journal:  Eur J Clin Microbiol       Date:  1987-06       Impact factor: 3.267

7.  Molecular analysis of Clostridium difficile strains isolated from 18 cases of recurrent clostridium difficile-associated diarrhea.

Authors:  Yajarayma Tang-Feldman; Susan Mayo; Joseph Silva; Stuart H Cohen
Journal:  J Clin Microbiol       Date:  2003-07       Impact factor: 5.948

Review 8.  Variations in virulence and molecular biology among emerging strains of Clostridium difficile.

Authors:  Jonathan J Hunt; Jimmy D Ballard
Journal:  Microbiol Mol Biol Rev       Date:  2013-12       Impact factor: 11.056

9.  Pseudomembranous colitis: how useful is endoscopy?

Authors:  J M Bergstein; A Kramer; D H Wittman; C Aprahamian; E J Quebbeman
Journal:  Surg Endosc       Date:  1990       Impact factor: 4.584

Review 10.  Clostridium difficile infection: a common clinical problem for the general internist.

Authors:  G M Caputo; M R Weitekamp; A E Bacon; C Whitener
Journal:  J Gen Intern Med       Date:  1994-09       Impact factor: 5.128

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.